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Abstract: Patients with chronic obstructive pulmonary disease (COPD) are often limited in their
activities by breathlessness. In these patients, exercise training may result in significant improvements
in dyspnea, exercise tolerance, and health related quality of life (HRQoL). Further possibilities are
to reduce ventilatory demand by decreasing the central respiratory drive or to lessen the perceived
breathing effort by increasing respiratory muscle strength through specific respiratory muscle
training. Upper limb training may also improve exercise capacity and symptoms in these patients
through the modulation of dynamic hyperinflation. Ventilatory assistance during exercise reduces
dyspnea and work of breathing and enhances exercise tolerance, although further studies should
be required to define their applicability in the routine pulmonary rehabilitation programs. Lung
volume resection surgery and lung transplantation in selected patients may control symptoms and
improve HRQoL.
Keywords: chronic obstructive pulmonary disease, dyspnea, nonpharmacologic treatment,
pulmonary rehabilitation.
Introduction
Dyspnea is the most common symptom of patients suffering from chronic obstructive
pulmonary disease (COPD). It progresses with the natural history of disease. Increased
breathlessness leads patients with severe COPD to inactivity and related peripheral
muscle deconditioning, resulting in a vicious cycle leading to further inactivity, social
isolation, fear of dyspnoea, and depression. With increasing severity of disease, drugs may
not be enough to alleviate dyspnea. In this review article we summarize the recent literature
concerning the nonpharmacological treatment of dyspnea in patients with COPD.
A search of MEDLINE research since 1966 including the terms, “Dyspnea/diet
therapy”  [MeSH] OR “Dyspnea/rehabilitation”  [MeSH] OR “Dyspnea/therapy”  [MeSH]
NOT “Dyspnea/drug therapy”  [MeSH], shows 1157 articles. We focused only on the
most significant original papers, reviews, and book chapters (in our view) and related
references since 2000.
What does dyspnea mean?
It is “a term used to characterize a subjective experience of breathing discomfort that
consists of qualitatively distinct sensations that vary in intensity. The experience
derives from interactions among multiple physiological, psychological, social, and
environmental factors, and may induce secondary physiological and behavioral
responses” (ATS 1999).
Respiratory sensation
Like pain, the subjective perception of dyspnea is an unpleasant physiologic sensation;
it is a signal to the conscious brain that there is a somehow disturbed physiologic state.
There are many similarities between dyspnea and pain, namely subjective
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characteristics, afferent pathways and cortical areas involved
(Mahler 2005). A common neural network underlying the
perception of both sensations has been suggested (von
Leupoldt and Dahme 2005). Chemo- and airways receptors,
lung parenchyma, and respiratory muscle receptors provide
sensory feedback via vagal, phrenic, and intercostals nerves
to the spinal cord, medulla, and higher centers of the central
nervous system (ATS 1999). According to the neuromechanical
dissociation theory a patient suffers from dyspnea when there
is a disparity between the central reflexic drive to breathe
and the appropriate mechanical response of the respiratory
system. The qualitative perception of dyspnea is contributed
also by the complex central processing of the afferent
feedback from peripheral sensory receptors. The inability of
COPD patients to expand rib cage appropriately in response
to the increased central drive to breathe contributes
importantly to the intensity and quality of dyspnea which
correlate with the degree of lung hyperinflation. Indeed the
descriptors chosen by patients invariably refer to inspiratory
difficulty and unsatisfied inspiration (O’Donnell and Webb
1993; O’Donnell et al 1997; Voduc et al 2005). The results of
neuroimaging studies have shown that distinct neural
networks subserve the respiratory discomfort related to loaded
breathing: the first is involved in the concomitant processing
of the genesis and perception of respiratory discomfort, the
second in the modulation of perceived intensity of the
sensation by various factors, including emotional processing
(Peiffer et al 2001).
Pathophysiological factors of
dyspnea in COPD
Different pathophysiological factors either singly or in
combination contribute to exertional dyspnea in COPD
patients: increased intrinsic mechanical loading of
inspiratory muscles, ie, the intrinsic positive end-expiratory
pressure (PEEPi), dynamic airways compression, greater
mechanical restriction of the thorax, inspiratory muscle
weakness, increased ventilatory demand relative to capacity,
gas exchange abnormalities, cardiovascular factors (Scano
and Ambrosino 2002). In COPD, the intensity and quality
of dyspnea during activity correlate with the magnitude of
lung hyperinflation which, in turn, results in severe
neuromechanical dissociation (Parker et al 2005).
Psychological aspects
Breathlessness is characterized by measurable intensity and
qualitative dimensions, which may vary depending on the
individual, the underlying disease, and other circumstances
(Scano and Ambrosino 2002). It is strongly related to the
Health Related Quality of Life (HRQoL) in COPD patients,
and the associated emotional responses contribute greatly to
the resulting morbidity (Gonzalez et al 2005). Depressive
symptoms are common in elderly patients, especially in those
who are most disabled (Yohannes et al 1998). Some data
suggest a possible benefit on HRQoL from antidepressant
drugs when depressive symptoms are present (Lacasse et al
2004). Episodes of dyspnea are often anticipated by and/or
associated with fear and anxiety. This increased physiological
arousal can precipitate or exacerbate dyspnea and contribute
to overall disability (Singer et al 2001; Dowson et al 2004).
Many of the currently available therapeutic interventions
relieve dyspnea by addressing a combination of different
mechanisms, namely: 1. reduction of ventilatory demand,
2. reduction of ventilatory impedance, 3. improvement in
ventilatory muscle function (Ambrosino and Scano 2001,
2004).
Exercise training
Reducing the metabolic load may result in reduced
ventilatory demand and therefore in dyspnea. Mild to severe
COPD patients of any age may obtain improvement in
dyspnea, exercise tolerance, and HRQoL as a result of exercise
training programs (Casaburi et al 1991; Baltzan et al 2004;
Nici et al 2006). The symptom improvement is multifactorial
and not fully understood. Exercise training results in
enhanced oxidative capacity and higher capillary density in
the trained muscles (Casaburi et al 1997; Maltais et al 1997).
A slower deeper breathing pattern develops by lowering
respiratory rate and increasing tidal volume (Casaburi 1995).
These changes may result in a reduction of the end-expiratory
lung volume, an improvement in dead space to tidal volume
ratio, a lower ventilatory requirement for exercise, and a
reduction in dynamic hyperinflation (Casaburi et al 1991;
Gigliotti et al 2003).
The greater physiological training response and exercise
tolerance can be achieved with high intensity training
programmes (above 80% of maximal work rate), rather than
with low intensity ones (below 50% of maximal work rate),
but no further gains in HRQoL are associated with these
additional physiological results (Puente-Maestu et al 2000).
An “intermittent” training modality may be better tolerated
and allows greater amount of work performed in COPD
subjects with more limited lung function (Sabapathy et al
2004).International Journal of COPD 2006:1(4) 357
COPD and dyspnea
Strength training promotes muscle growth and strength,
and may induce less dyspnea than aerobic exercise in COPD
patients. The combination of strength and aerobic training
seems to be a more physiologically complete approach (Saey
and Maltais 2005) although additional improvement in
exercise capacity and HRQoL are not clearly proven when
strength training is added to an aerobic training program.
Exercise training or at least stimulation to active life
should be offered to all symptomatic COPD patients (Nici
et al 2006).
Electrical stimulation
Neuromuscular electrical low-voltage stimulation (NMES)
has been shown to induce an increase in the muscular
oxidative capacities. Small controlled studies of this
technique in severe COPD patients have been reported (Neder
et al 2002; Bourjeily-Habr et al 2002; Zanotti et al 2003;
Ambrosino and Strambi 2004; Vivodzev et al 2006).
Not enough studies have been performed in order to
include NMES among the routine nonpharmacological
treatment of COPD patients.
Upper limb training
COPD patients often complain dyspnea for daily activities
requiring arm exercise, mostly related to the dynamic
hyperinflation. There is a relationship between upper limb
muscle strength and dyspnea (Dourado et al 2006). Some
data suggest an adjunctive effect of arm training in improving
exercise capacity and symptoms in stable COPD patients
and in patients recently weaned from mechanical ventilation
(Holland et al 2004; Gigliotti et al 2005; Porta et al 2005).
This is a promising tool especially in most severely
disabled patients.
Respiratory muscle training
Most COPD patients have inspiratory and expiratory muscle
weakness. The improvement in inspiratory muscle
performance obtained by specific controlled training is
associated with an improvement in the sensation of dyspnea,
exercise tolerance, and HRQoL. When the expiratory muscles
are specifically trained, a significant increase in exercise
performance has also been shown, but it does not appear to
be supplementary to the effect of inspiratory muscle training.
Although its clinical long-term effectiveness in COPD
patients must be confirmed, evidence is growing that specific
inspiratory muscle training is an important addition to
pulmonary rehabilitation programs whereas the role of
expiratory muscle training remains still unclear (Gosselink 2005;
Weiner and McConnell 2005; Hill et al 2006; Nici
et al 2006).
This is still a controversial topic. Further studies are
needed.
Breathing maneuvers
Different techniques are included under this term such as
pursed-lips breathing and diaphragmatic breathing.
Pursed-lips breathing
Pursed-lips breathing (PLB) is a technique attempting to
prolong active expiration through constricted lips. This
maneuver is routinely taught as a breathing retraining
exercise as it is often spontaneously
 adopted by COPD
patients to alleviate dyspnea. Compared with spontaneous
breathing, PLB reduces respiratory rate, dyspnea and arterial
carbon dioxide tension, and improves tidal volume and
arterial oxygenation at rest (Bianchi et al 2004). Not all
patients obtain dyspnea relief by PLB when performed
volitionally during exercise (Gosselink 2005; Spahija et al
2005). When PLB is done by patients who do not naturally
adopt this technique, a reduction in exercise respiratory rate
and recovery time is observed, and better results are found in
patients with higher resting breathlessness (Garrod et al 2005).
This is a very simple and useful maneuver spontaneously
adopted by patients and probably needs no instruction.
Diaphragmatic breathing
Diaphragmatic breathing is an old technique aimed to learn
to move the abdominal wall predominantly during inspiration
and to reduce upper rib cage motion. On an “experience basis”
this technique has for a long time been suggested to be
effective in reducing dyspnea in COPD patients although no
controlled randomized trials have confirmed this.
Furthermore, this modality has been recently found to be
accompanied by increased asynchronous and paradoxical
breathing movements, increased work of breathing with
related worsening in dyspnea (Vitacca et al 1998).
We would not teach such controversial maneuvers to
COPD patients.
Oxygen supplementation
A way to reduce metabolic load is oxygen supplementation.
Arterial hypoxia has a complex effect in resting and exercise
dyspnea. Critical hypoxia (<60mm Hg) (Voduc et al 2005)
can stimulate peripheral chemoreceptors whose afferentInternational Journal of COPD 2006:1(4) 358
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activity may reach consciousness. The hypoxemic
ventilatory stimulation however may contribute to
breathing discomfort by increasing the central motor output
and the respiratory muscle activation (Palange et al 2005).
Peripheral muscle hypoxia may alter sensory afferent
activity during exercise and respiratory muscle fatigue may
induce an increase in the motor activation.
Supplemental oxygen during exercise reduces exertional
breathlessness and improves exercise tolerance of the
hypoxemic COPD patient by different mechanisms: reduction
of hypoxic stimulation of the carotid bodies, pulmonary
vasodilation, and increase in arterial oxygen. The latter two
mechanisms may potentially reduce carotid body stimulation
at heavy levels of exercise by increasing oxygen delivery to
the exercising muscles and reducing carotid body stimulation
by lactic acidemia (Somfay et al 2002). Recent studies
indicate that oxygen administration during maximal exercise
can reduce the degree of dynamic hyperinflation, and lower
the degree of post-exertional dyspnea (O’Donnell et al 2001;
Stevenson and Calverley 2004). Supplemental oxygen
generally increases exercise tolerance in patients with only
mild to moderate hypoxemia (Fujimoto et al 2002).
Early studies (McDonald et al 1995; Rooyackers et al
1997; Fichter et al 1999; Garrod, Paul, et al 2000; Wadell
et al 2001) failed to demonstrate benefits of supplemental
oxygen during rehabilitation. Mild hypoxemia accelerates
peripheral muscle adaptation (Terrados et al 1990) so that
the use of supplemental oxygen during training of mildly
hypoxemic patients may not be advantageous. At difference
with those studies a recent double blind study (Emtner et al
2003) of nonhypoxemic patients with severe COPD showed
that patients trained with oxygen supplementation increased
training intensity and endurance more rapidly than patients
trained without. More recently it has been shown that by
combining the benefits of bronchodilators (reduced
hyperinflation)
 and O2 (reduced ventilatory drive), there are
additive effects on exercise endurance in patients with
normoxic COPD (Peters et al 2006).
Oxygen supplementation is a clear example of difference
between physiological concepts and practical application.
Further clinical, ranzomized, controlled studies are needed.
Air-Heliox mixtures
Heliox breathing can improve high-intensity exercise
endurance capacity in moderate-severe COPD by reducing
airflow limitation, dynamic hyperinflation, and dyspnea
sensation (Palange et al 2004, 2005; Laude et al 2006).
Assisted ventilation
Several studies have examined the acute effects of different
modalities of ventilatory assistance during exercise on
dyspnea and exercise tolerance in advanced COPD
(Ambrosino and Strambi 2004). Assisted ventilation, either
delivered through nasal or facial mask during exercise,
reduces dyspnea and work of breathing and enhance exercise
tolerance in COPD patients (van’t Hul et al 2002). The
commonly accepted explanation of these effects is that
continuous positive airway pressure counterbalances the
PEEPi and the related inspiratory threshold load; whereas
inspiratory pressure support (IPS) provides symptomatic
benefit by unloading and assisting the overburdened
ventilatory muscles, reducing fatigue and allowing greater
training workload (Petrof et al 1990; Hawkins et al 2002).
Two similar studies of well structured programs of exercise
training with proportional assist ventilation have given
conflicting results (Bianchi et al 2002; Hawkins et al 2002).
Nevertheless, the role of assisted ventilation in pulmonary
rehabilitation is still controversial. The additional benefit
of assisted ventilation on exercise tolerance, dyspnoea, and
health status was not clearly demonstrated when compared
with training alone. More recently, a randomized controlled
study evaluated the effects of training with IPS ventilation
comparing two levels of IPS: 10cmH2O and 5cmH2O; no
information about the use of an external positive end-
expiratory pressure (PEEP) was provided. Significantly
larger improvements in exercise performance resulted with
the higher level of IPS, whereas no differences on health
status were observed (van’t Hul et al 2006).
Larger prospective controlled studies should be required
to determine if assisted ventilation may eventually have a
routine applicability, and in which subgroups of patients
(Ambrosino 2006).
An improvement in dyspnea and HRQoL was shown as
result of domiciliary noninvasive positive pressure
ventilation added to long term oxygen (Clini et al 2002).
Home nocturnal noninvasive ventilation added to daytime
exercise training has been found to significantly increase
exercise capacity and quality of life compared with exercise
training alone (Garrod, Mikelsons, et al 2000).
Psychological support
The encouraging psychological effect of controlled
exercise training can also contribute to increase exercise
tolerance at higher levels of breathing discomfort and
overcome the patient’s fear of dyspnea (Voduc et al 2005).International Journal of COPD 2006:1(4) 359
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Developing an adequate support system is a most important
component of pulmonary rehabilitation (Guell et al 2006).
Patients with chronic respiratory disease will benefit from
supportive counseling to address their concerns, either
individually or in a group format (Nici et al 2006). Treating
depression may make a significant difference in the patient’s
quality of life. However, while moderate levels of anxiety
or depression may be addressed in the pulmonary
rehabilitation program, patients identified as having
significant psychosocial disturbances should be referred
to an appropriate mental health practitioner prior to the
start of the program (Emery 1993; Kim et al 2000; Nici et al
2006).
Surgical treatment
Lung volume reduction surgery (LVRS) has become more
widely accepted in selected patients with severe
symptomatic emphysema. Bilateral LVRS procedures appear
to result in greater short-term improvement than unilateral
LVRS, whereas physiological benefits appear similar with
video-assisted thoracoscopy or median sternotomy
techniques (Make 2005).
Several studies comparing the effects of pulmonary
rehabilitation with those of LVRS found a greater
improvement in physiological parameters, exercise, and
HRQoL in patients receiving LVRS compared with patients
who continued pulmonary rehabilitation; the effects were
showed stable for 6 months to 1 year.
The underlying lung disease, co-morbidities, and
associated physiological abnormalities often impact the
outcome of LVRS. Many of these factors may be modified by
standard medical care and by comprehensive pulmonary
rehabilitation programs. Patients with upper-lobe
predominant emphysema and a low post-rehabilitation
exercise tolerance exhibited a decreased risk of mortality
after LVRS.
Patients with upper lobe predominant emphysema and a
high post-rehabilitation exercise capacity or patients with
nonupper lobe predominant emphysema and a low post-
rehabilitation exercise capacity do not have a survival
advantage or disadvantage, whereas those with upper lobe
predominant emphysema treated surgically are more likely
to improve their exercise capacity after surgery.
Higher mortality with LVRS than with medical management
was found: 1. in patients with severely impaired lung function
(post-bronchodilator forced expiratory volume in 1 second
[FEV1] ≤20% predicted and diffusing capacity for carbon
monoxide (DLCO) ≤20% predicted) or homogeneous
emphysema; 2. in patients with nonupper lobe predominant
emphysema and a high post-rehabilitation exercise capacity.
In severe emphysema, LVRS improved health status in
survivors but was associated with higher mortality risk
(Martinez and Chang 2005).
Lung transplantation is an option for a more limited
number of patients. A COPD patient can be considered an
appropriate candidate for transplantation when the FEV1 is
below 25% predicted and/or the pressure of carbon dioxide
(PaCO2) is ≥ 55mm Hg.
Pulmonary function generally improves after lung
transplantation, but exercise capacity remains below
predicted values, primarily due to a peripheral muscle
myopathy. Pulmonary rehabilitation programs can improve
the exercise tolerance and HRQoL, in both short and long
term after lung transplantation (Gay and Martinez 2005).
Long-term results of lung transplantation are limited by
significant complications that impair survival; an
approximately 80% 1-year, 50% 5-year, and 35% 10-year
survival has been reported. Bronchiolitis obliterans is the
most important long-term complication of lung
transplantation resulting in decreased pulmonary function
(Hillerdal et al 2005; Martinez and Chang 2005; Miller et al
2005).
Conclusion
Although drug therapy remains the main corner of
comprehensive treatment of dyspnoea in COPD patients,
there are also several nonpharmacological approaches.
Exercise training programs represent the best cost-effective
modalities to add to pharmacological treatment of COPD.
Other interventions like education, nutrition, psychological
counseling should be used as adjuncts to well-designed
comprehensive respiratory rehabilitation programs and
tailored to the specific patient (Nici et al 2006). Surgical
option should be confined to most disabled and/or end-
stage patients.
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